nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Pyruvate metabolism—BSG—melanoma	0.00454	0.0779	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—BSG—melanoma	0.0044	0.0754	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—CEACAM1—melanoma	0.00299	0.0513	CbGpPWpGaD
Foscarnet—Neuropathy—Docetaxel—melanoma	0.00277	0.00294	CcSEcCtD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—SDHD—melanoma	0.00275	0.0471	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—melanoma	0.00275	0.0471	CbGpPWpGaD
Foscarnet—Pancytopenia—Carmustine—melanoma	0.00273	0.0029	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00272	0.00289	CcSEcCtD
Foscarnet—Sweating increased—Temozolomide—melanoma	0.00271	0.00288	CcSEcCtD
Foscarnet—Neutropenia—Carmustine—melanoma	0.00269	0.00286	CcSEcCtD
Foscarnet—Decreased appetite—Vemurafenib—melanoma	0.00269	0.00286	CcSEcCtD
Foscarnet—Fatigue—Vemurafenib—melanoma	0.00267	0.00283	CcSEcCtD
Foscarnet—Neoplasm—Docetaxel—melanoma	0.00267	0.00283	CcSEcCtD
Foscarnet—Constipation—Vemurafenib—melanoma	0.00265	0.00281	CcSEcCtD
Foscarnet—Pancytopenia—Temozolomide—melanoma	0.00264	0.00281	CcSEcCtD
Foscarnet—Hypoaesthesia—Bleomycin—melanoma	0.00263	0.00279	CcSEcCtD
Foscarnet—Neutropenia—Temozolomide—melanoma	0.0026	0.00276	CcSEcCtD
Foscarnet—Dysuria—Temozolomide—melanoma	0.0026	0.00276	CcSEcCtD
Foscarnet—Agranulocytosis—Dactinomycin—melanoma	0.00256	0.00272	CcSEcCtD
Foscarnet—Sepsis—Docetaxel—melanoma	0.00256	0.00272	CcSEcCtD
Foscarnet—Renal failure—Carmustine—melanoma	0.00252	0.00268	CcSEcCtD
Foscarnet—Weight decreased—Temozolomide—melanoma	0.00252	0.00267	CcSEcCtD
Foscarnet—Neuropathy peripheral—Carmustine—melanoma	0.00252	0.00267	CcSEcCtD
Foscarnet—Urinary tract infection—Carmustine—melanoma	0.00249	0.00265	CcSEcCtD
Foscarnet—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00246	0.00261	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00246	0.00261	CcSEcCtD
Foscarnet—Flushing—Bleomycin—melanoma	0.00245	0.0026	CcSEcCtD
Foscarnet—Body temperature increased—Vemurafenib—melanoma	0.00245	0.0026	CcSEcCtD
Foscarnet—Pharyngitis—Dactinomycin—melanoma	0.00244	0.00259	CcSEcCtD
Foscarnet—Neuropathy peripheral—Temozolomide—melanoma	0.00243	0.00258	CcSEcCtD
Foscarnet—Urinary tract infection—Temozolomide—melanoma	0.00241	0.00256	CcSEcCtD
Foscarnet—Chills—Bleomycin—melanoma	0.00237	0.00251	CcSEcCtD
Foscarnet—Erythema multiforme—Dactinomycin—melanoma	0.00233	0.00247	CcSEcCtD
Foscarnet—Sinusitis—Temozolomide—melanoma	0.00233	0.00247	CcSEcCtD
Foscarnet—Hallucination—Carmustine—melanoma	0.00229	0.00243	CcSEcCtD
Foscarnet—Hypoaesthesia—Carmustine—melanoma	0.00229	0.00243	CcSEcCtD
Foscarnet—Flushing—Dactinomycin—melanoma	0.00228	0.00243	CcSEcCtD
Foscarnet—Renal impairment—Docetaxel—melanoma	0.00225	0.00239	CcSEcCtD
Foscarnet—Dermatitis bullous—Docetaxel—melanoma	0.00224	0.00238	CcSEcCtD
Foscarnet—Asthenia—Vemurafenib—melanoma	0.00222	0.00236	CcSEcCtD
Foscarnet—Hallucination—Temozolomide—melanoma	0.00222	0.00235	CcSEcCtD
Foscarnet—Hypoaesthesia—Temozolomide—melanoma	0.00222	0.00235	CcSEcCtD
Foscarnet—Pharyngitis—Temozolomide—melanoma	0.00221	0.00235	CcSEcCtD
Foscarnet—Chills—Dactinomycin—melanoma	0.00221	0.00235	CcSEcCtD
Foscarnet—Pruritus—Vemurafenib—melanoma	0.00219	0.00233	CcSEcCtD
Foscarnet—Urethral disorder—Temozolomide—melanoma	0.00218	0.00232	CcSEcCtD
Foscarnet—Eye disorder—Carmustine—melanoma	0.00215	0.00229	CcSEcCtD
Foscarnet—Hyponatraemia—Docetaxel—melanoma	0.00215	0.00228	CcSEcCtD
Foscarnet—Flushing—Carmustine—melanoma	0.00214	0.00227	CcSEcCtD
Foscarnet—Ill-defined disorder—Bleomycin—melanoma	0.00213	0.00226	CcSEcCtD
Foscarnet—Anaemia—Bleomycin—melanoma	0.00212	0.00226	CcSEcCtD
Foscarnet—Diarrhoea—Vemurafenib—melanoma	0.00212	0.00225	CcSEcCtD
Foscarnet—Erythema multiforme—Temozolomide—melanoma	0.0021	0.00224	CcSEcCtD
Foscarnet—Eye disorder—Temozolomide—melanoma	0.00208	0.00221	CcSEcCtD
Foscarnet—Malaise—Bleomycin—melanoma	0.00207	0.0022	CcSEcCtD
Foscarnet—Flushing—Temozolomide—melanoma	0.00207	0.00219	CcSEcCtD
Foscarnet—Leukopenia—Bleomycin—melanoma	0.00206	0.00218	CcSEcCtD
Foscarnet—Dizziness—Vemurafenib—melanoma	0.00205	0.00217	CcSEcCtD
Foscarnet—SLC16A1—Basigin interactions—ITGB1—melanoma	0.00202	0.0346	CbGpPWpGaD
Foscarnet—Ataxia—Docetaxel—melanoma	0.00201	0.00214	CcSEcCtD
Foscarnet—Cough—Bleomycin—melanoma	0.002	0.00213	CcSEcCtD
Foscarnet—Chills—Temozolomide—melanoma	0.002	0.00212	CcSEcCtD
Foscarnet—Dehydration—Docetaxel—melanoma	0.00199	0.00211	CcSEcCtD
Foscarnet—Ill-defined disorder—Dactinomycin—melanoma	0.00199	0.00211	CcSEcCtD
Foscarnet—Anaemia—Dactinomycin—melanoma	0.00198	0.0021	CcSEcCtD
Foscarnet—Vomiting—Vemurafenib—melanoma	0.00197	0.00209	CcSEcCtD
Foscarnet—Myalgia—Bleomycin—melanoma	0.00196	0.00208	CcSEcCtD
Foscarnet—Chest pain—Bleomycin—melanoma	0.00196	0.00208	CcSEcCtD
Foscarnet—Rash—Vemurafenib—melanoma	0.00195	0.00207	CcSEcCtD
Foscarnet—Dermatitis—Vemurafenib—melanoma	0.00195	0.00207	CcSEcCtD
Foscarnet—Back pain—Carmustine—melanoma	0.00194	0.00206	CcSEcCtD
Foscarnet—Headache—Vemurafenib—melanoma	0.00194	0.00206	CcSEcCtD
Foscarnet—Discomfort—Bleomycin—melanoma	0.00193	0.00205	CcSEcCtD
Foscarnet—Malaise—Dactinomycin—melanoma	0.00193	0.00205	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00193	0.00205	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00193	0.00205	CcSEcCtD
Foscarnet—Leukopenia—Dactinomycin—melanoma	0.00192	0.00204	CcSEcCtD
Foscarnet—Confusional state—Bleomycin—melanoma	0.00189	0.00201	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Docetaxel—melanoma	0.00189	0.002	CcSEcCtD
Foscarnet—Tremor—Carmustine—melanoma	0.00188	0.002	CcSEcCtD
Foscarnet—Oedema—Bleomycin—melanoma	0.00188	0.00199	CcSEcCtD
Foscarnet—Back pain—Temozolomide—melanoma	0.00187	0.00199	CcSEcCtD
Foscarnet—Infection—Bleomycin—melanoma	0.00186	0.00198	CcSEcCtD
Foscarnet—Anaemia—Carmustine—melanoma	0.00185	0.00197	CcSEcCtD
Foscarnet—Dysphagia—Docetaxel—melanoma	0.00185	0.00196	CcSEcCtD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.00184	0.0316	CbGpPWpGaD
Foscarnet—Agitation—Carmustine—melanoma	0.00184	0.00196	CcSEcCtD
Foscarnet—Nausea—Vemurafenib—melanoma	0.00184	0.00195	CcSEcCtD
Foscarnet—Thrombocytopenia—Bleomycin—melanoma	0.00184	0.00195	CcSEcCtD
Foscarnet—Myalgia—Dactinomycin—melanoma	0.00182	0.00194	CcSEcCtD
Foscarnet—Bronchospasm—Docetaxel—melanoma	0.00182	0.00193	CcSEcCtD
Foscarnet—Tremor—Temozolomide—melanoma	0.00182	0.00193	CcSEcCtD
Foscarnet—Discomfort—Dactinomycin—melanoma	0.0018	0.00191	CcSEcCtD
Foscarnet—Ill-defined disorder—Temozolomide—melanoma	0.0018	0.00191	CcSEcCtD
Foscarnet—Leukopenia—Carmustine—melanoma	0.0018	0.00191	CcSEcCtD
Foscarnet—Anaemia—Temozolomide—melanoma	0.00179	0.0019	CcSEcCtD
Foscarnet—Anorexia—Bleomycin—melanoma	0.00179	0.0019	CcSEcCtD
Foscarnet—Agitation—Temozolomide—melanoma	0.00178	0.00189	CcSEcCtD
Foscarnet—Pancytopenia—Docetaxel—melanoma	0.00176	0.00187	CcSEcCtD
Foscarnet—Hypotension—Bleomycin—melanoma	0.00175	0.00186	CcSEcCtD
Foscarnet—Oedema—Dactinomycin—melanoma	0.00175	0.00186	CcSEcCtD
Foscarnet—Malaise—Temozolomide—melanoma	0.00175	0.00186	CcSEcCtD
Foscarnet—Convulsion—Carmustine—melanoma	0.00174	0.00185	CcSEcCtD
Foscarnet—Infection—Dactinomycin—melanoma	0.00174	0.00184	CcSEcCtD
Foscarnet—Leukopenia—Temozolomide—melanoma	0.00173	0.00184	CcSEcCtD
Foscarnet—Hypertension—Carmustine—melanoma	0.00173	0.00184	CcSEcCtD
Foscarnet—Neutropenia—Docetaxel—melanoma	0.00173	0.00184	CcSEcCtD
Foscarnet—Palpitations—Temozolomide—melanoma	0.00171	0.00182	CcSEcCtD
Foscarnet—Thrombocytopenia—Dactinomycin—melanoma	0.00171	0.00182	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Bleomycin—melanoma	0.00171	0.00181	CcSEcCtD
Foscarnet—Myalgia—Carmustine—melanoma	0.00171	0.00181	CcSEcCtD
Foscarnet—Chest pain—Carmustine—melanoma	0.00171	0.00181	CcSEcCtD
Foscarnet—Anxiety—Carmustine—melanoma	0.0017	0.00181	CcSEcCtD
Foscarnet—Cough—Temozolomide—melanoma	0.00169	0.0018	CcSEcCtD
Foscarnet—Paraesthesia—Bleomycin—melanoma	0.00168	0.00179	CcSEcCtD
Foscarnet—Convulsion—Temozolomide—melanoma	0.00168	0.00178	CcSEcCtD
Foscarnet—Weight decreased—Docetaxel—melanoma	0.00167	0.00178	CcSEcCtD
Foscarnet—Hypertension—Temozolomide—melanoma	0.00167	0.00178	CcSEcCtD
Foscarnet—Dyspnoea—Bleomycin—melanoma	0.00167	0.00178	CcSEcCtD
Foscarnet—Anorexia—Dactinomycin—melanoma	0.00167	0.00177	CcSEcCtD
Foscarnet—Confusional state—Carmustine—melanoma	0.00165	0.00175	CcSEcCtD
Foscarnet—Myalgia—Temozolomide—melanoma	0.00165	0.00175	CcSEcCtD
Foscarnet—Arthralgia—Temozolomide—melanoma	0.00165	0.00175	CcSEcCtD
Foscarnet—Anxiety—Temozolomide—melanoma	0.00164	0.00175	CcSEcCtD
Foscarnet—Oedema—Carmustine—melanoma	0.00164	0.00174	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00164	0.00174	CcSEcCtD
Foscarnet—Discomfort—Temozolomide—melanoma	0.00163	0.00173	CcSEcCtD
Foscarnet—Decreased appetite—Bleomycin—melanoma	0.00163	0.00173	CcSEcCtD
Foscarnet—Infection—Carmustine—melanoma	0.00163	0.00173	CcSEcCtD
Foscarnet—Renal failure—Docetaxel—melanoma	0.00162	0.00172	CcSEcCtD
Foscarnet—Neuropathy peripheral—Docetaxel—melanoma	0.00162	0.00172	CcSEcCtD
Foscarnet—Dry mouth—Temozolomide—melanoma	0.00161	0.00171	CcSEcCtD
Foscarnet—Pain—Bleomycin—melanoma	0.0016	0.0017	CcSEcCtD
Foscarnet—Conjunctivitis—Docetaxel—melanoma	0.0016	0.0017	CcSEcCtD
Foscarnet—Thrombocytopenia—Carmustine—melanoma	0.0016	0.0017	CcSEcCtD
Foscarnet—Confusional state—Temozolomide—melanoma	0.00159	0.00169	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00159	0.00169	CcSEcCtD
Foscarnet—Oedema—Temozolomide—melanoma	0.00158	0.00168	CcSEcCtD
Foscarnet—Infection—Temozolomide—melanoma	0.00157	0.00167	CcSEcCtD
Foscarnet—SLC16A1—Basigin interactions—MMP1—melanoma	0.00157	0.0269	CbGpPWpGaD
Foscarnet—Anorexia—Carmustine—melanoma	0.00156	0.00166	CcSEcCtD
Foscarnet—Thrombocytopenia—Temozolomide—melanoma	0.00155	0.00164	CcSEcCtD
Foscarnet—Feeling abnormal—Bleomycin—melanoma	0.00155	0.00164	CcSEcCtD
Foscarnet—Agranulocytosis—Docetaxel—melanoma	0.00154	0.00163	CcSEcCtD
Foscarnet—Hypotension—Carmustine—melanoma	0.00153	0.00162	CcSEcCtD
Foscarnet—Hyperhidrosis—Temozolomide—melanoma	0.00153	0.00162	CcSEcCtD
Foscarnet—Decreased appetite—Dactinomycin—melanoma	0.00152	0.00161	CcSEcCtD
Foscarnet—Fatigue—Dactinomycin—melanoma	0.00151	0.0016	CcSEcCtD
Foscarnet—Anorexia—Temozolomide—melanoma	0.00151	0.0016	CcSEcCtD
Foscarnet—Pain—Dactinomycin—melanoma	0.0015	0.00159	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Carmustine—melanoma	0.00149	0.00158	CcSEcCtD
Foscarnet—Rhinitis—Docetaxel—melanoma	0.00148	0.00158	CcSEcCtD
Foscarnet—Body temperature increased—Bleomycin—melanoma	0.00148	0.00157	CcSEcCtD
Foscarnet—Insomnia—Carmustine—melanoma	0.00148	0.00157	CcSEcCtD
Foscarnet—Hypoaesthesia—Docetaxel—melanoma	0.00147	0.00156	CcSEcCtD
Foscarnet—Paraesthesia—Carmustine—melanoma	0.00147	0.00156	CcSEcCtD
Foscarnet—Pharyngitis—Docetaxel—melanoma	0.00147	0.00156	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—BSG—melanoma	0.00146	0.0251	CbGpPWpGaD
Foscarnet—Dyspnoea—Carmustine—melanoma	0.00146	0.00155	CcSEcCtD
Foscarnet—Somnolence—Carmustine—melanoma	0.00146	0.00155	CcSEcCtD
Foscarnet—Urethral disorder—Docetaxel—melanoma	0.00145	0.00154	CcSEcCtD
Foscarnet—Feeling abnormal—Dactinomycin—melanoma	0.00144	0.00153	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Temozolomide—melanoma	0.00144	0.00153	CcSEcCtD
Foscarnet—Insomnia—Temozolomide—melanoma	0.00143	0.00152	CcSEcCtD
Foscarnet—Gastrointestinal pain—Dactinomycin—melanoma	0.00143	0.00152	CcSEcCtD
Foscarnet—Decreased appetite—Carmustine—melanoma	0.00142	0.00151	CcSEcCtD
Foscarnet—Paraesthesia—Temozolomide—melanoma	0.00142	0.00151	CcSEcCtD
Foscarnet—Dyspnoea—Temozolomide—melanoma	0.00141	0.0015	CcSEcCtD
Foscarnet—Somnolence—Temozolomide—melanoma	0.00141	0.00149	CcSEcCtD
Foscarnet—Erythema multiforme—Docetaxel—melanoma	0.0014	0.00149	CcSEcCtD
Foscarnet—Constipation—Carmustine—melanoma	0.0014	0.00149	CcSEcCtD
Foscarnet—Pain—Carmustine—melanoma	0.0014	0.00149	CcSEcCtD
Foscarnet—Dyspepsia—Temozolomide—melanoma	0.00139	0.00148	CcSEcCtD
Foscarnet—Eye disorder—Docetaxel—melanoma	0.00138	0.00147	CcSEcCtD
Foscarnet—Abdominal pain—Dactinomycin—melanoma	0.00138	0.00147	CcSEcCtD
Foscarnet—Body temperature increased—Dactinomycin—melanoma	0.00138	0.00147	CcSEcCtD
Foscarnet—Decreased appetite—Temozolomide—melanoma	0.00137	0.00146	CcSEcCtD
Foscarnet—Flushing—Docetaxel—melanoma	0.00137	0.00146	CcSEcCtD
Foscarnet—Fatigue—Temozolomide—melanoma	0.00136	0.00145	CcSEcCtD
Foscarnet—Constipation—Temozolomide—melanoma	0.00135	0.00144	CcSEcCtD
Foscarnet—Pain—Temozolomide—melanoma	0.00135	0.00144	CcSEcCtD
Foscarnet—Feeling abnormal—Carmustine—melanoma	0.00135	0.00143	CcSEcCtD
Foscarnet—Asthenia—Bleomycin—melanoma	0.00135	0.00143	CcSEcCtD
Foscarnet—Gastrointestinal pain—Carmustine—melanoma	0.00134	0.00142	CcSEcCtD
Foscarnet—Chills—Docetaxel—melanoma	0.00133	0.00141	CcSEcCtD
Foscarnet—Pruritus—Bleomycin—melanoma	0.00133	0.00141	CcSEcCtD
Foscarnet—Feeling abnormal—Temozolomide—melanoma	0.0013	0.00138	CcSEcCtD
Foscarnet—Body temperature increased—Carmustine—melanoma	0.00129	0.00137	CcSEcCtD
Foscarnet—Abdominal pain—Carmustine—melanoma	0.00129	0.00137	CcSEcCtD
Foscarnet—Gastrointestinal pain—Temozolomide—melanoma	0.00129	0.00137	CcSEcCtD
Foscarnet—Asthenia—Dactinomycin—melanoma	0.00125	0.00133	CcSEcCtD
Foscarnet—Abdominal pain—Temozolomide—melanoma	0.00125	0.00133	CcSEcCtD
Foscarnet—Body temperature increased—Temozolomide—melanoma	0.00125	0.00133	CcSEcCtD
Foscarnet—Back pain—Docetaxel—melanoma	0.00125	0.00132	CcSEcCtD
Foscarnet—Muscle spasms—Docetaxel—melanoma	0.00124	0.00132	CcSEcCtD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.0012	0.0205	CbGpPWpGaD
Foscarnet—Diarrhoea—Dactinomycin—melanoma	0.0012	0.00127	CcSEcCtD
Foscarnet—Vomiting—Bleomycin—melanoma	0.00119	0.00127	CcSEcCtD
Foscarnet—Anaemia—Docetaxel—melanoma	0.00119	0.00126	CcSEcCtD
Foscarnet—Rash—Bleomycin—melanoma	0.00118	0.00126	CcSEcCtD
Foscarnet—Dermatitis—Bleomycin—melanoma	0.00118	0.00125	CcSEcCtD
Foscarnet—Asthenia—Carmustine—melanoma	0.00117	0.00125	CcSEcCtD
Foscarnet—Leukopenia—Docetaxel—melanoma	0.00115	0.00123	CcSEcCtD
Foscarnet—Palpitations—Docetaxel—melanoma	0.00114	0.00121	CcSEcCtD
Foscarnet—Asthenia—Temozolomide—melanoma	0.00113	0.00121	CcSEcCtD
Foscarnet—Cough—Docetaxel—melanoma	0.00112	0.00119	CcSEcCtD
Foscarnet—Diarrhoea—Carmustine—melanoma	0.00112	0.00119	CcSEcCtD
Foscarnet—Pruritus—Temozolomide—melanoma	0.00112	0.00119	CcSEcCtD
Foscarnet—Convulsion—Docetaxel—melanoma	0.00112	0.00119	CcSEcCtD
Foscarnet—Nausea—Bleomycin—melanoma	0.00111	0.00118	CcSEcCtD
Foscarnet—Hypertension—Docetaxel—melanoma	0.00111	0.00118	CcSEcCtD
Foscarnet—Vomiting—Dactinomycin—melanoma	0.00111	0.00118	CcSEcCtD
Foscarnet—Rash—Dactinomycin—melanoma	0.0011	0.00117	CcSEcCtD
Foscarnet—Chest pain—Docetaxel—melanoma	0.0011	0.00117	CcSEcCtD
Foscarnet—Arthralgia—Docetaxel—melanoma	0.0011	0.00117	CcSEcCtD
Foscarnet—Myalgia—Docetaxel—melanoma	0.0011	0.00117	CcSEcCtD
Foscarnet—Dizziness—Carmustine—melanoma	0.00108	0.00115	CcSEcCtD
Foscarnet—Diarrhoea—Temozolomide—melanoma	0.00108	0.00115	CcSEcCtD
Foscarnet—Dry mouth—Docetaxel—melanoma	0.00107	0.00114	CcSEcCtD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—SDHD—melanoma	0.00107	0.0183	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—BSG—melanoma	0.00107	0.0183	CbGpPWpGaD
Foscarnet—Confusional state—Docetaxel—melanoma	0.00106	0.00113	CcSEcCtD
Foscarnet—Oedema—Docetaxel—melanoma	0.00105	0.00112	CcSEcCtD
Foscarnet—Dizziness—Temozolomide—melanoma	0.00105	0.00111	CcSEcCtD
Foscarnet—Infection—Docetaxel—melanoma	0.00104	0.00111	CcSEcCtD
Foscarnet—Vomiting—Carmustine—melanoma	0.00104	0.00111	CcSEcCtD
Foscarnet—Nausea—Dactinomycin—melanoma	0.00104	0.0011	CcSEcCtD
Foscarnet—Rash—Carmustine—melanoma	0.00103	0.0011	CcSEcCtD
Foscarnet—Dermatitis—Carmustine—melanoma	0.00103	0.00109	CcSEcCtD
Foscarnet—Thrombocytopenia—Docetaxel—melanoma	0.00103	0.00109	CcSEcCtD
Foscarnet—Headache—Carmustine—melanoma	0.00103	0.00109	CcSEcCtD
Foscarnet—Vomiting—Temozolomide—melanoma	0.00101	0.00107	CcSEcCtD
Foscarnet—Anorexia—Docetaxel—melanoma	0.001	0.00106	CcSEcCtD
Foscarnet—Rash—Temozolomide—melanoma	0.000997	0.00106	CcSEcCtD
Foscarnet—Dermatitis—Temozolomide—melanoma	0.000996	0.00106	CcSEcCtD
Foscarnet—Headache—Temozolomide—melanoma	0.000991	0.00105	CcSEcCtD
Foscarnet—Hypotension—Docetaxel—melanoma	0.000983	0.00104	CcSEcCtD
Foscarnet—Nausea—Carmustine—melanoma	0.000972	0.00103	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000959	0.0164	CbGpPWpGaD
Foscarnet—Musculoskeletal discomfort—Docetaxel—melanoma	0.000958	0.00102	CcSEcCtD
Foscarnet—Insomnia—Docetaxel—melanoma	0.000951	0.00101	CcSEcCtD
Foscarnet—Paraesthesia—Docetaxel—melanoma	0.000944	0.001	CcSEcCtD
Foscarnet—Nausea—Temozolomide—melanoma	0.00094	0.000998	CcSEcCtD
Foscarnet—Dyspnoea—Docetaxel—melanoma	0.000938	0.000996	CcSEcCtD
Foscarnet—Somnolence—Docetaxel—melanoma	0.000935	0.000993	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000927	0.0159	CbGpPWpGaD
Foscarnet—Dyspepsia—Docetaxel—melanoma	0.000926	0.000983	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000923	0.0158	CbGpPWpGaD
Foscarnet—Decreased appetite—Docetaxel—melanoma	0.000914	0.000971	CcSEcCtD
Foscarnet—Fatigue—Docetaxel—melanoma	0.000907	0.000963	CcSEcCtD
Foscarnet—Pain—Docetaxel—melanoma	0.000899	0.000955	CcSEcCtD
Foscarnet—Constipation—Docetaxel—melanoma	0.000899	0.000955	CcSEcCtD
Foscarnet—Feeling abnormal—Docetaxel—melanoma	0.000867	0.00092	CcSEcCtD
Foscarnet—Gastrointestinal pain—Docetaxel—melanoma	0.00086	0.000913	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000838	0.0144	CbGpPWpGaD
Foscarnet—Body temperature increased—Docetaxel—melanoma	0.000832	0.000883	CcSEcCtD
Foscarnet—Abdominal pain—Docetaxel—melanoma	0.000832	0.000883	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—CEACAM1—melanoma	0.000812	0.0139	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—ITGA4—melanoma	0.000801	0.0137	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—CD44—melanoma	0.000801	0.0137	CbGpPWpGaD
Foscarnet—Asthenia—Docetaxel—melanoma	0.000755	0.000801	CcSEcCtD
Foscarnet—Pruritus—Docetaxel—melanoma	0.000744	0.00079	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—ITGAV—melanoma	0.000739	0.0127	CbGpPWpGaD
Foscarnet—Diarrhoea—Docetaxel—melanoma	0.00072	0.000764	CcSEcCtD
Foscarnet—Dizziness—Docetaxel—melanoma	0.000696	0.000739	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—ITGB1—melanoma	0.000671	0.0115	CbGpPWpGaD
Foscarnet—Vomiting—Docetaxel—melanoma	0.000669	0.00071	CcSEcCtD
Foscarnet—Rash—Docetaxel—melanoma	0.000663	0.000704	CcSEcCtD
Foscarnet—Dermatitis—Docetaxel—melanoma	0.000663	0.000704	CcSEcCtD
Foscarnet—Headache—Docetaxel—melanoma	0.000659	0.0007	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ARL2—melanoma	0.000643	0.011	CbGpPWpGaD
Foscarnet—Nausea—Docetaxel—melanoma	0.000625	0.000663	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000622	0.0107	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCB5—melanoma	0.000602	0.0103	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000599	0.0103	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—ITGB3—melanoma	0.000582	0.00998	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000544	0.00932	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—MMP1—melanoma	0.000522	0.00895	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000487	0.00835	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—FN1—melanoma	0.000476	0.00817	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000469	0.00804	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000426	0.0073	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ARL2—melanoma	0.000417	0.00715	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—BSG—melanoma	0.000396	0.0068	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IFNA5—melanoma	0.000384	0.00658	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000383	0.00657	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—FLNA—melanoma	0.000373	0.00639	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CB—melanoma	0.000349	0.00599	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CLU—melanoma	0.000337	0.00578	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RHOB—melanoma	0.00033	0.00566	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ACER3—melanoma	0.000329	0.00564	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000316	0.00542	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000304	0.00522	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—UGT2B10—melanoma	0.000301	0.00516	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RAC2—melanoma	0.000296	0.00507	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—VEGFC—melanoma	0.000291	0.00499	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HS3ST5—melanoma	0.00028	0.0048	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000276	0.00474	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—NRAS—melanoma	0.000269	0.00462	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SPARC—melanoma	0.000255	0.00438	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—F2R—melanoma	0.000255	0.00438	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000249	0.00426	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HSPA5—melanoma	0.000239	0.0041	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GAB2—melanoma	0.000234	0.00401	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GNA11—melanoma	0.000234	0.00401	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—KRAS—melanoma	0.000232	0.00397	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HDAC2—melanoma	0.00022	0.00377	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GNAQ—melanoma	0.000217	0.00372	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CD44—melanoma	0.000217	0.00372	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ITGA4—melanoma	0.000217	0.00372	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IFNB1—melanoma	0.000216	0.0037	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—melanoma	0.000213	0.00365	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PLCB4—melanoma	0.000212	0.00364	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IFNA1—melanoma	0.00021	0.00361	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SYK—melanoma	0.000204	0.0035	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—AKT3—melanoma	0.0002	0.00344	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ITGAV—melanoma	0.0002	0.00344	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIP4K2A—melanoma	0.000199	0.00342	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC6A11—melanoma	0.000199	0.00342	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—HRAS—melanoma	0.000197	0.00338	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IFNA2—melanoma	0.000196	0.00336	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000195	0.00334	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MTAP—melanoma	0.000194	0.00333	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—ALB—melanoma	0.000183	0.00313	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ITGB1—melanoma	0.000182	0.00312	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PHGDH—melanoma	0.000173	0.00296	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—LUM—melanoma	0.000173	0.00296	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HPSE—melanoma	0.00017	0.00291	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HGF—melanoma	0.000166	0.00285	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CUBN—melanoma	0.000166	0.00285	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CSF2—melanoma	0.000165	0.00282	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SDHD—melanoma	0.000161	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CSPG4—melanoma	0.000161	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—BSG—melanoma	0.000161	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ITGB3—melanoma	0.000158	0.00271	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PRKCA—melanoma	0.000158	0.00271	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GPAM—melanoma	0.000156	0.00267	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000148	0.00255	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RAC1—melanoma	0.000146	0.00251	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MMP1—melanoma	0.000142	0.00243	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CDK2—melanoma	0.000139	0.00238	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PLA2G6—melanoma	0.000132	0.00227	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—FN1—melanoma	0.000129	0.00221	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—NOS2—melanoma	0.000128	0.00219	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000126	0.00217	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CG—melanoma	0.000124	0.00212	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—EGF—melanoma	0.000122	0.0021	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—VCAN—melanoma	0.000119	0.00204	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	0.000119	0.00203	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IGF1—melanoma	0.000113	0.00194	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CD—melanoma	0.000109	0.00186	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ALB—melanoma	0.000107	0.00184	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP17A1—melanoma	0.0001	0.00172	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	9.64e-05	0.00165	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GNA11—melanoma	9.47e-05	0.00162	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CB—melanoma	9.47e-05	0.00162	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ALB—melanoma	9.29e-05	0.00159	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—FASN—melanoma	9.27e-05	0.00159	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC5A5—melanoma	9.12e-05	0.00156	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CD44—melanoma	8.81e-05	0.00151	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GNAQ—melanoma	8.81e-05	0.00151	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IL2—melanoma	8.7e-05	0.00149	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP1B1—melanoma	8.44e-05	0.00145	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—VEGFA—melanoma	7.39e-05	0.00127	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—NRAS—melanoma	7.3e-05	0.00125	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MAPK3—melanoma	6.99e-05	0.0012	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCB1—melanoma	6.95e-05	0.00119	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MAPK1—melanoma	6.65e-05	0.00114	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PRKCA—melanoma	6.4e-05	0.0011	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ERCC2—melanoma	6.35e-05	0.00109	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KRAS—melanoma	6.29e-05	0.00108	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	6.03e-05	0.00103	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CA—melanoma	5.77e-05	0.00099	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TP53—melanoma	5.59e-05	0.000958	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HRAS—melanoma	5.34e-05	0.000916	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CG—melanoma	5.01e-05	0.000859	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPARG—melanoma	4.84e-05	0.000829	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—AKT1—melanoma	4.72e-05	0.000809	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CD—melanoma	4.41e-05	0.000755	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALB—melanoma	4.35e-05	0.000746	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CB—melanoma	3.84e-05	0.000658	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGS2—melanoma	3.81e-05	0.000652	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTEN—melanoma	3.32e-05	0.000569	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CA—melanoma	2.34e-05	0.000401	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AKT1—melanoma	1.91e-05	0.000328	CbGpPWpGaD
